Harnessing new players in atherosclerosis to treat heart disease
Symposium - New York, United States
Atherosclerosis is defined as a chronic inflammatory disease affecting arterial blood vessels involving dysregulation of the endothelial-leukocyte adhesive interactions, increased leukocyte apoptosis within the plaque, and defective phagocytosis of apoptotic cells. Despite the key role of monocytes/macrophages in atherosclerosis, mounting evidence suggests that dysregulation of other cell types may be independent risk factors for atherosclerosis. Leukocytes are produced daily and are derived from hematopoietic stem and progenitor cells within the bone marrow in a process call hematopoiesis. A better understanding of this process will open an avenue to identify new targets to fight atherosclerosis.
Organization: New York Academy of Sciences
(Courtesy of New York Academy of Sciences, via starrynightlights.com)
Harnessing new players in atherosclerosis to treat heart disease
Tuesday, September 24, 2013 | 8:30 AM - 4:30 PM
New York Academy of Sciences
250 Greenwich Street, 40th Floor, New York, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
